12 June 2025 Pharmaceuticals TGA ‘Major step forward’: TGA approves first pharmacological therapy for OSA
12 June 2025 Biologics EULAR Psoriatic Athritis Early biologic intervention yields lasting benefit in PsA
12 June 2025 cardiovascular Clinical research Pharmaceuticals Rheumatoid Arthritis Upadacitinib outperforms adalimumab regardless of CV risk
12 June 2025 ARA Rheumatology Workforce ARA’s new push to address chronic rheumatology workforce crisis